New developments in the use of monoclonal antibodies in the therapy of genitourinary cancer
- 24 December 2001
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 86 (2) , 165-171
- https://doi.org/10.1046/j.1464-410x.2000.00751.x
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Angiogenesis and anti-angiogenesis: Perspectives for the treatment of solid tumorsAnnals of Oncology, 1999
- Radioimmunotherapy of DU-145 Tumours in Nude Mice: A Pilot Study with E4, A Novel Monoclonal Antibody Against Prostate CancerActa Oncologica, 1999
- THE ROLE OF MONOCLONAL ANTIBODY IN THE MANAGEMENT OF PROSTATE ADENOCARCINOMAJournal of Urology, 1998
- L6 monoclonal antibody binds prostate cancerThe Prostate, 1998
- Monoclonal antibody 7E11.C5 staining of viable LNCaP cellsThe Prostate, 1997
- Radioimmunotherapy of prostatic adenocarcinomas: Effects of 131I‐labelled E4 antibodies on cells at different depth in DU 145 spheroidsInternational Journal of Cancer, 1995
- Generation, Characterization, andin VivoStudies of Humanized Anticarcinoma Antibody CC49Hybridoma, 1995
- Biochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate-specific membrane antigenUrologic Oncology: Seminars and Original Investigations, 1995
- Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853)Urology, 1993
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975